Effect of methandrostenolone on serum triglyceride and cholesterol levels in diabetic patients

Acta Med Acad Sci Hung. 1975;32(1):27-34.

Abstract

Eighteen adult diabetic patients were treated with methandrostenolone in daily doses of 15 mg for 3 weeks. Serum triglyceride and cholesterol levels and lipoprotein lipase activity were determined before and after treatment. In patients with intense hypertriglyceridaemia, triglyceride concentration decreased and, with the exception of a single patient, lipoprotein lipase activity returned to normal. Cholesterol concentration did not change characteristically.

MeSH terms

  • Blood Glucose
  • Body Weight
  • Cholesterol / blood*
  • Diabetes Complications
  • Diabetes Mellitus / blood*
  • Diabetes Mellitus / drug therapy
  • Female
  • Glycosuria
  • Humans
  • Hyperlipidemias / blood
  • Hyperlipidemias / complications
  • Lipoprotein Lipase / blood
  • Male
  • Methandrostenolone / pharmacology*
  • Methandrostenolone / therapeutic use
  • Middle Aged
  • Triglycerides / blood*

Substances

  • Blood Glucose
  • Triglycerides
  • Cholesterol
  • Methandrostenolone
  • Lipoprotein Lipase